These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21030103)

  • 1. Efficacy of occasional self-monitoring of postprandial blood glucose levels in type 2 diabetic patients without insulin therapy.
    Shiraiwa T; Takahara M; Kaneto H; Miyatsuka T; Yamamoto K; Yoshiuchi K; Sakamoto K; Matsuoka TA; Matsuhisa M; Yamasaki Y; Shimomura I
    Diabetes Res Clin Pract; 2010 Dec; 90(3):e91-2. PubMed ID: 21030103
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical inquiries. Does daily monitoring of blood glucose predict hemoglobin A1c levels?
    Rose E; Ketchell D; Markova T
    J Fam Pract; 2003 Jun; 52(6):485-90. PubMed ID: 12791231
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements.
    Dailey G
    Mayo Clin Proc; 2007 Feb; 82(2):229-35; quiz 236. PubMed ID: 17290732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study.
    Borg R; Kuenen JC; Carstensen B; Zheng H; Nathan DM; Heine RJ; Nerup J; Borch-Johnsen K; Witte DR;
    Diabetes; 2010 Jul; 59(7):1585-90. PubMed ID: 20424232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.
    Zhang DA; Katznelson L; Li M
    J Diabetes Sci Technol; 2012 Mar; 6(2):289-93. PubMed ID: 22538137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study.
    Bergenstal RM; Bode BW; Tamler R; Trence DL; Stenger P; Schachner HC; Fullam J; Pardo S; Kohut T; Fisher WA
    Diabetes Technol Ther; 2012 Oct; 14(10):851-7. PubMed ID: 23013200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy.
    Mukherjee JJ; Majumdar S; Ray S
    J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.
    Matsuura K; Mori Y; Nakamura A; Yokoyama J; Utsunomiya K
    Diabetes Technol Ther; 2012 May; 14(5):423-9. PubMed ID: 22316114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA1c levels are better predicted by prebreakfast than postbreakfast blood glucose self-analyses in type 2 diabetes. Influence of duration of diabetes and mode of treatment.
    Relimpio F; Guerrero R; Martínez-Brocca MA
    Acta Diabetol; 2007 Jun; 44(2):55-9. PubMed ID: 17530467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of postprandial glucose excursions throughout the day in newly diagnosed type 2 diabetes.
    Cichosz SL; Fleischer J; Hoeyem P; Laugesen E; Poulsen PL; Christiansen JS; Ejskjaer N; Hansen TK
    Diabetes Technol Ther; 2013 Jan; 15(1):78-83. PubMed ID: 23176177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing postprandial glucose levels in patients with diabetes.
    Tenzer-Iglesias P; Brunton S
    J Fam Pract; 2008 Jan; 57(1 Suppl Managing):S17-24. PubMed ID: 18662529
    [No Abstract]   [Full Text] [Related]  

  • 12. Self-monitoring of blood glucose in type 2 diabetes: is the debate (finally) ending?
    Ceriello A
    Diabetes Res Clin Pract; 2012 Jul; 97(1):1-2. PubMed ID: 22503946
    [No Abstract]   [Full Text] [Related]  

  • 13. I rely more on self-monitoring of blood glucose than HbA
    Tyagi K
    Diabetes Metab Syndr; 2020; 14(3):173-174. PubMed ID: 32142997
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardization of self-monitoring of blood glucose and continuous glucose monitoring reporting.
    Garg SK
    Diabetes Technol Ther; 2013 Mar; 15(3):193. PubMed ID: 23451793
    [No Abstract]   [Full Text] [Related]  

  • 15. Postprandial or Fasting Hyperglycemia: Time to Move On?
    DeVries JH
    Diabetes Technol Ther; 2015 Jul; 17(7):441-2. PubMed ID: 26062102
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of a new insulinotropic agent by using an innovative technology: efficacy and safety of nateglinide determined by continuous glucose monitoring.
    Abrahamian H; Francesconi M; Loiskandl A; Dzien A; Prager R; Weitgasser R
    Diabetes Technol Ther; 2004 Feb; 6(1):31-7. PubMed ID: 15000767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood glucose control in type 2 diabetes. Basic requirements for reducing vascular complications].
    Seissler J
    Internist (Berl); 2007 Jul; 48(7):676, 678-80, 682 passim. PubMed ID: 17541528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of postprandial glycemia].
    Lehmann R
    Praxis (Bern 1994); 2001 Mar; 90(9):345-8. PubMed ID: 11268922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A compensated type 2 diabetic patient? Fasting blood glucose can be deceptive].
    MMW Fortschr Med; 2004 Feb; 146(7):62. PubMed ID: 15347061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.